References for Sentinel Lymph Node Biopsy

Back to Sentinel Lymph Node Biopsy

Bass SS, Cox CE, Ku NN, Berman C, Reintgen D. (1999) The Role of Sentinel Lymph Node Biopsy in Breast Cancer. J. Am. Coll. of Surgery Vol. 189, no 2, August 1999, 183-194. https://www.journalacs.org/article/S1072-7515(99)00130-1/pdf
Bembenek A, Kettelhack C, Reuhl T. (et al). (2000) “Sentinel” lymph node biopsy in breast carcinoma. Current experiences. Zentralbl Chir 2000;125:817-821 https://www.ncbi.nlm.nih.gov/pubmed/11098576
Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES. (et al). (2000) Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer. Journal of Clinical Oncology, Vol 18, Issue 20 (October), 2000: 3480-3486 https://www.ncbi.nlm.nih.gov/pubmed/11032588
Cao Q, Wang S, Liu X, Lin L, Zhao J. (2007) Sentinel lymph node micrometastasis detection using immunohistochemistry and reverse transcription-polymerase chain reaction for cytokeratin 19 in breast cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 11074
Coombs N, Chen W, Taylor R, Boyages J. (2007) A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Breast J 2007;13:593-598. https://www.ncbi.nlm.nih.gov/pubmed/17983402
Elias N, Tanabe K, Sober AJ, Gadd M.A, Mihm MC, Goodspeed B, Cosimi AB. (2004) Is Completion Lymphadenectomy After a Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma Always Necessary? Arch Surg. 2004;139:400-405. https://www.ncbi.nlm.nih.gov/pubmed/15078708
Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER. (et al). (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997 Jul;15(7):2483-93. https://www.ncbi.nlm.nih.gov/pubmed/9215816
Jakub JW, Pendas S, Reintgen DS. (2003) Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies The Oncologist, Vol. 8, No. 1, 59-68, February 2003 https://www.ncbi.nlm.nih.gov/pubmed/12604732
Mansel RE, Fallowfield L, Kissin M. (et al). (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609 https://www.ncbi.nlm.nih.gov/pubmed/16670385
Moran CJ, Kell Mr, Flanagan FL. (et al). (2007) Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Am J Surg 2007;194:172-175 https://www.ncbi.nlm.nih.gov/pubmed/17618799
Kaleya R, Heckman J, Most M, Zager J. Lymphatic mapping and sentinel node biopsy: A surgical perspective. Seminars in Nuclear Medicine. Volume 35, Issue 2, Pages 129-134
Kelley MC, Hansen N, McMasters KM. (2004) Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer. American Journal of Surgery. 188 (2004) 49-61. https://www.ncbi.nlm.nih.gov/pubmed/15219485
Moghimi M, Ghoddosi I, Rahimabadi AE, Sheikhvatan, M. (2009) Accuracy of Sentinel Node Biopsy in breast cancer patients with a high prevalence of axillary metastases. Scandinavian Journal of Surgery 98: 30-33, 2009 https://www.ncbi.nlm.nih.gov/pubmed/19447739
Taback B, Hansen N, Conway K, Giuliano A. (2004) Recurrence patterns following a negative sentinel lymph node biopsy in patients with early-stage breast cancer. Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 560 http://ascopubs.org/doi/abs/10.1200/jco.2004.22.90140.560
Vijayakumar V, Boerner PS, Vani AB, Vijayakumar S. (2005) A Critical Review of Variables Affecting the Accuracy and False-Negative Rate of Sentinel Node Biopsy Procedures in Early Breast Cancer. Nuclear Medicine Communication 2005; 26: 395-405. https://www.ncbi.nlm.nih.gov/pubmed/15838421

Back to Sentinel Lymph Node Biopsy